Profile | GDS2987 / GI_40549458-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 17.3 | 51 |
GSM215244 | HMVEC_vehicle_rep2 | 25.2 | 53 |
GSM215253 | HMVEC_vehicle_rep3 | 34.2 | 66 |
GSM215254 | HMVEC_atorvastatin_rep1 | 26.9 | 55 |
GSM215282 | HMVEC_atorvastatin_rep3 | 14.2 | 32 |
GSM215344 | HMVEC_atorvastatin_rep2 | 12.3 | 30 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 16.4 | 31 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 44 | 62 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 23 | 36 |
GSM215294 | HMVEC_SLx2119_rep1 | 19.3 | 55 |
GSM215295 | HMVEC_SLx2119_rep2 | 9.4 | 19 |
GSM215296 | HMVEC_SLx2119_rep3 | 52.1 | 63 |
GSM215297 | PASMC_vehicle_rep1 | 8.4 | 13 |
GSM215298 | PASMC_vehicle_rep2 | 4.2 | 7 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | 49.8 | 63 |
GSM215312 | PASMC_atorvastatin_rep2 | 24.9 | 38 |
GSM215313 | PASMC_atorvastatin_rep3 | 16.6 | 25 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 18.2 | 30 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 4.5 | 9 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 20.4 | 34 |
GSM215327 | PASMC_SLx2119_rep1 | 13.5 | 24 |
GSM215328 | PASMC_SLx2119_rep2 | 37.5 | 55 |
GSM215329 | PASMC_SLx2119_rep3 | 12.3 | 24 |
GSM215330 | Fibroblasts_vehicle_rep1 | 26.5 | 51 |
GSM215331 | Fibroblasts_vehicle_rep2 | 1.8 | 5 |
GSM215332 | Fibroblasts_vehicle_rep3 | 13.6 | 41 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | ||
GSM215334 | Fibroblasts_atorvastatin_rep2 | 13.5 | 36 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | ||
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 3 | 10 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 0.1 | 0 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 14 | 37 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 15.7 | 42 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 13.6 | 36 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 4.8 | 13 |